已知或疑似非酒精性脂肪性肝病成人肝右叶超声衰减系数与背向散射系数的重复性与再现性
前瞻性研究纳入41例已知或疑似非酒精性脂肪性肝病成人,由临床超声技师用临床扫描仪对肝右叶行同日超声检查,每例2次扫描试验(试验间重新定位),每次试验用2个换能器,每个换能器在固定机器设置下采集3次肝脏数据及外部校准体模数据,测量2.6至3.0 MHz的衰减系数与背向散射系数。结果显示衰减系数与对数转换背向散射系数的组内相关系数在未重新定位时分别为0.88至0.94和0.87至0.95,试验间重新定位后分别为0.80至0.84和0.69至0.82(3幅试验内图像平均后),换能器引入的变异小于重复性误差。结论认为基于参考体模技术的肝脏衰减系数与背向散射系数测量在已知或疑似非酒精性脂肪性肝病成人中具有重复性且换能器间具有再现性。
要点
- 未重新定位时衰减系数组内相关系数0.88至0.94,对数转换背向散射系数0.87至0.95。
- 试验间重新定位后衰减系数组内相关系数0.80至0.84,对数转换背向散射系数0.69至0.82(3幅图像平均)。
- 换能器引入的变异小于重复性误差,支持换能器间测量可重复。
核心结论
- 使用临床扫描仪和参考体模技术测量的肝脏衰减系数与背向散射系数在已知或疑似非酒精性脂肪性肝病成人中具有重复性,且换能器间具有再现性。
研究设计与样本
- 经机构审查委员会批准、符合《健康保险流通与责任法案》的前瞻性研究,纳入41例已知或疑似非酒精性脂肪性肝病研究参与者,由临床超声技师用临床扫描仪对肝右叶行同日超声检查。
关键影像表现/征象
- 每个换能器在超声技师优化后保持机器设置恒定,从肝脏采集3次数据(不重新定位参与者),再从外部校准体模采集数据,记录原始射频回波数据。
- 在用户定义的肝脏感兴趣区内测量2.6至3.0 MHz的衰减系数与背向散射系数。
- 平均衰减系数为0.94 dB/cm-MHz,平均对数转换背向散射系数为-27.0 dB。
诊断标准与关键数值
- 未重新定位参与者时,衰减系数组内相关系数为0.88至0.94,对数转换背向散射系数组内相关系数为0.87至0.95。
- 试验间重新定位重复扫描时,衰减系数组内相关系数为0.80至0.84,对数转换背向散射系数在平均3幅试验内图像后组内相关系数为0.69至0.82。
- 换能器引入的变异小于重复性误差。
临床应用与阅片要点
- 测量肝右叶衰减系数与背向散射系数时,可采用参考体模技术校准临床扫描仪,并在同一换能器下保持机器设置恒定。
- 试验间重新定位可降低重复性,报告时应考虑定位差异对组内相关系数的影响(衰减系数0.80至0.84,对数转换背向散射系数0.69至0.82)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the repeatability and reproducibility of the ultrasonic attenuation coefficient (AC) and backscatter coefficient (BSC) measured in the livers of adults with known or suspected nonalcoholic fatty liver disease (NAFLD).
METHODS: The Institutional Review Board approved this Health Insurance Portability and Accountability Act-compliant prospective study; informed consent was obtained. Forty-one research participants with known or suspected NAFLD were recruited and underwent same-day ultrasound examinations of the right liver lobe with a clinical scanner by a clinical sonographer. Each participant underwent 2 scanning trials, with participant repositioning between trials. Two transducers were used in each trial. For each transducer, machine settings were optimized by the sonographer but then kept constant while 3 data acquisitions were obtained from the liver without participant repositioning and then from an external calibrated phantom. Raw RF echo data were recorded. The AC and BSC were measured within 2.6 to 3.0 MHz from a user-defined hepatic field of interest from each acquisition. The repeatability and reproducibility were analyzed by random-effects models.
RESULTS: The mean AC and log-transformed BSC (logBSC) were 0.94 dB/cm-MHz and -27.0 dB, respectively. Intraclass correlation coefficients were 0.88 to 0.94 for the AC and 0.87 to 0.95 for the logBSC acquired without participant repositioning. For between-trial repeated scans with participant repositioning, the intraclass correlation coefficients were 0.80 to 0.84 for the AC and 0.69 to 0.82 for the logBSC after averaging results from 3 within-trial images. The variability introduced by the transducer was less than the repeatability error.
CONCLUSIONS: Hepatic AC and BSC measures using a reference phantom technique on a clinical scanner are repeatable and reproducible between transducers in adults with known or suspected NAFLD.
引用
- Han A, Andre MP, Deiranieh L, et al. Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease. J Ultrasound Med. 2018. PMID: 29359454. doi:10.1002/jum.14537
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。